Table I.
Demographic and experience characteristics of dermatopathologists (N=149)
| Pathologist characteristics | N (%) |
|---|---|
| Demographics | |
| Age (y) | |
| <40 | 26 (17%) |
| 40–49 | 64 (43%) |
| 50–59 | 39 (26%) |
| ≥60 | 20 (13%) |
| Sex | |
| Female | 46 (31%) |
| Male | 101 (68%) |
| Prefer not to answer | 2 (1%) |
| Geographical region∗ | |
| Northeast | 29 (19%) |
| Midwest | 44 (30%) |
| Southern | 61 (41%) |
| Western | 15 (10%) |
| Training and experience | |
| Affiliation with an academic medical center | |
| No | 71 (48%) |
| Yes, adjunct/affiliated | 46 (31%) |
| Yes, primary appointment | 32 (21%) |
| Residency† | |
| Anatomic pathology | 26 (17%) |
| Anatomic/Clinical pathology | 81 (54%) |
| Dermatology | 50 (34%) |
| Other‡ | 3 (2%) |
| Fellowship† | |
| No fellowship | 2 (1%) |
| Surgical pathology | 29 (19%) |
| Dermatopathology | 147 (99%) |
| Other§ | 11 (7%) |
| Board certification† | |
| Not board-certified | 0 (0%) |
| Dermatology | 49 (33%) |
| Anatomic pathology | 107 (72%) |
| Clinical pathology | 77 (52%) |
| Dermatopathologyװ | 148 (99%) |
| Other¶ | 10 (7%) |
| Years of interpreting melanocytic skin lesions | |
| <5 | 18 (12%) |
| 5–9 | 38 (26%) |
| 10–19 | 62 (42%) |
| ≥20 | 31 (21%) |
| Percent of caseload interpreting melanocytic skin lesions | |
| <10% | 7 (5%) |
| 10%-24% | 72 (48%) |
| 25%-49% | 52 (35%) |
| ≥50% | 18 (12%) |
| Are you already familiar with the MPATH-Dx classification tool? | |
| No | 80 (54%) |
| Unsure | 21 (14%) |
| Yes | 48 (32%) |
MPATH-Dx, Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis.
US Census Bureau Regions: https://www.census.gov/prod/1/gen/95statab/preface.pdf.
Pathologists could make multiple selections; therefore, percentages may sum to greater than 100%.
‘Other’ includes residencies in internal medicine and general surgery.
‘Other’ includes the following responses for fellowship training: cytopathology, gastrointestinal and Hepatic pathology, hematology, hematopathology, molecular pathology, soft tissue pathology, and transfusion medicine.
One participant reported fellowship training in dermatopathology but was not board-certified in dermatopathology.
‘Other’ includes the following responses for board certification: cytopathology, DI/DLI, forensic pathology, hematology, hematopathology, internal medicine, and transfusion medicine.